Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia

NCT00281918 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

817

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]